Zinc and redox signaling: Perturbations associated with cardiovascular disease and diabetes mellitus

Antioxidants and Redox Signaling

Volumn 13, Issue 10, 2010, Pages 1549-1573

  Foster, Meika ^a   Samman, Samir ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COPPER ZINC SUPEROXIDE DISMUTASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EXTRACELLULAR SUPEROXIDE DISMUTASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; LEPTIN; MANGANESE SUPEROXIDE DISMUTASE; METALLOTHIONEIN; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; ZINC;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE; CELLULAR STRESS RESPONSE; DIABETES MELLITUS; DIET SUPPLEMENTATION; DYSLIPIDEMIA; GENE; GENE MUTATION; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INTRACELLULAR SIGNALING; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; ZINC DEFICIENCY; ZNT8 GENE;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; ZINC;

EID: 77957744890     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3111     Document Type: Review

References (236)

1. Abdallah SM and Samman S. The effect of increasing dietary zinc on the activity of superoxide dismutase and zinc concentration in erythrocytes of healthy female subjects. EJCN 47: 327-332, 1993.
2. Afkhami-Ardekani M, Karimi M, Mohammadi SM, and Nourani F. Effect of zinc supplementation on lipid and glucose in type 2 diabetic patients. Pak J Nutr 7: 550-553, 2008.
3. Allan AK, Hawksworth GM, Woodhouse LR, Sutherland B, King JC, and Beattie JH. Lymphocyte metallothionein mRNA responds to marginal zinc intake in human volunteers. Br J Nutr 84: 747-756, 2000.
4. Al-Maroof RA and Al-Sharbatti SS. Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics. Saudi Med J 27: 344-350, 2006.
5. Anderson RA, Roussel AM, Zouari N, Mahjoub S, Matheau JM, and Kerkeni A. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr 20: 212-218, 2001.
6. Andriollo-Sanchez M, Hininger-Favier I, Meunier N, Ven-neria E, O'Connor JM, Maiani G, Polito A, Bord S, Ferry M, Coudray C, and Roussel AM. No antioxidant beneficial effect of zinc supplementation on oxidative stress markers and antioxidant defenses in middle-aged and elderly subjects: the Zenith Study. J Am Coll Nutr 27: 463-469, 2008.
7. Arai K, Iizuka S, Tada Y, Oikawa K, and Taniguchi N. Increase in the glucosylated form of erythrocyte Cu-Zn-superoxide dismutase in diabetes and close association of the nonenzymatic glucosylation with the enzyme activity. Biochim Biophys Acta 924: 292-296, 1987.
8. Auld DS. Zinc coordination sphere in biochemical zinc sites. Biometals 14: 271-313, 2001.
9. Aydemir TB, Blanchard RK, and Cousins RJ. Zinc supplementation of young men alters metallothionein, zinc transporter, and cytokine gene expression in leukocyte populations. Proc Natl Acad Sci USA 103: 1699-1704, 2006.
10. phox in human coronary arteries. Circulation 100: 1494-1498, 1999.
11. Bannister JV, Bannister WH, and Rotilio G. Aspects of the structure, function, and applications of superoxide dis-mutase. CRC Crit Rev Biochem 22: 111-180, 1987.
12. Bao B, Prasad AS, Beck FWJ, Fitzgerald JT, Snell D, Bao GW, Singh T, and Cardozo LJ. Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am J Clin Nutr 91: 1634-1641, 2010.
13. Bao B, Prasad A, Beck FW, Suneja A, and Sarkar F. Toxic effect of zinc on NF-kappaB, IL-2, IL-2 receptor alpha, and TNF-alpha in HUT-78 (Th(0)) cells. Toxicol Lett 166: 222-228, 2006.
14. Bao S, Liu MJ, Lee B, Besecker B, Lai JP, Guttridge DC, and Knoell DL. Zinc modulates the innate immune response in vivo to polymicrobial sepsis through regulation of NF-kB. Am J Physiol Lung Cell Mol Physiol 298: L744-L754, 2010.
15. Barthel A, Ostrakhovitch EA, Walter PL, Kampkötter A, and Klotz LO. Stimulation of phoshoinositide 3-kinase=Akt signaling by copper and zinc ions: mechanisms and consequences. Arch Biochem Biophys 463: 175-182, 2007.
16. Bastie CC, Nahle Z, McLoughlin T, Esser K, Zhang W, Unterman T, and Abumrad NA. FoxO1 stimulates fatty acid uptake and oxidation in muscle cells through CD36-dependent and-independent mechanisms. J Biol Chem 280: 14222-14229, 2005.
17. Beattie JH and Kwun IS. Is zinc deficiency a risk factor for atherosclerosis? Br J Nutr 91: 177-181, 2004.
18. Beletate V, El Dib RP, and Atallah AN. Zinc supplementation for the prevention of type 2 diabetes mellitus. Co-chrane Database Syst Rev 24: CD005525, 2007.
19. Bełtowski J. Role of leptin in blood pressure regulation and arterial hypertension. J Hypertens 24: 789-801, 2006.
20. Bettger WJ, Fish TJ, and O'Dell BL. Effects of copper and zinc status of rats on erythrocyte stability and superoxide dismutase activity. Proc Soc Exp Biol Med 158: 279-282, 1978.
21. Beyersmann D and Haase H. Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Bio-metals 14: 331-341, 2001.
22. Black MR, Medeiros DM, Brunett E, and Welke R. Zinc supplements and serum lipids in young adult white males. Am J Clin Nutr 47: 970-975, 1988.
23. 2-induced activation of ERK 1=2, p38 MAPK, and protein kinase B signaling in vascular smooth muscle cells. Antioxid Redox Signal 6: 353-366, 2004.
24. Bogden JD, Oleske JM, Lavenhar MA, Munves EM, Kemp FW, Bruening KS, Holding KJ, Denny TN, Guarino MA, Krieger LM, and Holland BK. Zinc and immunocompe-tence in elderly people: effects of zinc supplementation for 3 months. Am J Clin Nutr 48: 655-663, 1988.
25. Bonham M, O'Connor JM, McAnena LB, Walsh PM, Downes CS, Hannigan BM, and Strain JJ. Zinc supplementation has no effect on lipoprotein metabolism, hemostasis, and putative indices of copper status in healthy men. Biol Trace Elem Res 93: 75-86, 2003.
26. Boucher JL and Hurrell DG. Cardiovascular disease and diabetes. Diabetes Spectrum 21: 154-155, 2008.
27. Bourcier T, Sukhova G, and Libby P. The nuclear factor kB signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem 272: 15817-15824, 1997.
28. Bray TM and Bettger WJ. The physiological role of zinc as an antioxidant. Free Rad Biol Med 8: 281-291, 1990.
29. Bremner I, Morrison JN, Wood AM, and Arthur JR. Effects of changes in dietary zinc, copper and selenium supply and of endotoxin administration on metallothionein I concentrations in blood cells and urine in the rat. J Nutr 117: 1595-1602, 1987.
30. Bruinsma JJ, Jirakulaporn T, Muslin AJ, and Kornfeld K. Zinc ions and cation diffusion facilitator proteins regulate Ras-mediated signaling. Dev Cell 2: 567: 578, 2002.
31. Cao J, Bobo JA, Liuzzi JP, and Cousins RJ. Effects of in-tracellular zinc depletion on metallothionein and ZIP2 transporter expression and apoptosis. J Leukoc Biol 70: 559-566, 2001.
32. Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, and Shah AM. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 8: 691-728, 2006.
33. Ceddia RB. Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis. Int J Obes 29: 1175-1183, 2005.
34. Chen H, Carlson EC, Pellet L, Moritz JT, and Epstein PN. Overexpression of metallothionein in pancreatic b-cells reduces streptozotocin-induced DNA damage and diabetes. Diabetes 50: 2040-2046, 2001.
35. Chen WS, Peng XD, Wang Y, Xu PZ, Chen ML, Luo Y, Jeon SM, Coleman K, Haschek WM, Bass J, Philipson LH, and Hay N. Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice. Mol Cell Biol 29: 3151-3162, 2009.
36. Cherian MG and Apostolova MD. Nuclear localization of metallothionein during cell proliferation and differentiation. Cell Mol Biol 46: 347-356, 2000.
37. Chimienti F, Devergnas S, Pattou F, Schuit F, Garcia-Cuenca R, Vandewalle B, Kerr-Conte J, Van Lommel L, Grunwald D, Favier A, and Seve M. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci 119: 4199-4206, 2006.
38. Chou SS, Clegg MS, Momma TY, Niles BJ, Duffy JY, Daston GP, and Keen CL. Alterations in protein kinase C activity and processing during zinc-deficiency-induced cell death. Biochem J 383: 63-71, 2004.
39. Chvapil M. New aspects in the biological role of zinc: a stabilizer of macromolecules and biological membranes. Life Sci 13: 1041-1049, 1973.
40. Cortese MM, Suschek CV, Wetzel W, Kröncke KD, and Kolb-Bachofen V. Zinc protects endothelial cells from hydrogen peroxide via Nrf2-dependent stimulation of gluta-thione biosynthesis. Free Rad Biol Med 44: 2002-2012, 2008.
41. Cortese-Krott MM, Suschek CV, Wetzel W, Kröncke KD, and Kolb-Bachofen V. Nitric oxide-mediated protection of endothelial cells from hydrogen peroxide is mediated by intracellular zinc and glutathione. Am J Physiol Cell Physiol 296: 811-820, 2009.
42. Cousins RJ, Liuzzi JP, and Lichten LA. Mammalian zinc transport, trafficking, and signals. J Biol Chem 281: 24085-24089, 2006.
43. Cragg RA, Phillips SR, Piper JM, Varma JS, Campbell FC, Mathers JC, and Ford D. Homeostatic regulation of zinc transporters in the human small intestine by dietary zinc supplementation. Gut 54: 469-478, 2005.
44. Crouse SF, Hooper PL, Atterbom HA, and Papenfuss RL. Zinc Ingestion and Lipoprotein Values in Sedentary and Endurance-Trained Men. JAMA 252: 785-787, 1984.
45. Csermely P, Szamel M, Resch K, and Somogyi J. Zinc can increase the activity of protein kinase C and contributes to its binding to the plasma membrane in T lymphocytes. J Biol Chem 263: 6487-6490, 1988.
46. Cunningham JJ, Fu A, Mearkle PL, and Brown RG. Hy-perzincuria in individuals with insulin-dependent diabetes mellitus: concurrent zinc status and the effect of high-dose zinc supplementation. Metabolism 43: 1558-1562, 1994.
47. Dalton TP, Li Q, Bittel D, Liang L, and Andrews GK. Oxidative stress activates metal-responsive transcription factors-1 binding activity. Occupancy in vivo of metal response elements in the metallothionein-I gene promoter. J Biol Chem 271: 26233-26241, 1996.
48. Davis CD, Milne DB, and Nielsen FH. Changes in dietary zinc and copper affect zinc-status indicators of postmeno-pausal women, notably, extracellular superoxide dismutase and amyloid precursor proteins. Am J Clin Nutr 71: 781-788, 2000.
49. De Martin R, Hoeth M, Hofer-Warbinek R, and Schmid JA. The transcription factor NF-kB and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol 20: e83-e88, 2000.
50. De Sena KC, Arrais RF, das Gracas Almeida M, de Araujo DM, dos Santos MM, de Lima VT, and de Fatima Campos Pedrosa L. Effects of zinc supplementation in patients with type 1 diabetes. Biol Trace Elem Res 105: 1-9, 2005.
51. Dimitrova AA, Strashimirov D, Betova T, Russeva A, and Alexandrova M. Zinc content in the diet affects the activity of CuZnSOD, lipid peroxidation and lipid profile of spontaneously hypertensive rats. Acta Biol Hung 59: 305-314, 2008.
52. DiSilvestro RA. Zinc in relation to diabetes and oxidative disease. J Nutr 130: 1509S-1511S, 2000.
53. DiSilvestro RA and Blostein-Fujii A. Moderate zinc deficiency in rats enhances lipoprotein oxidation in vitro. Free Rad Biol Med 22: 739-742, 1997.
54. Donath MY, Böni-Schnetzler M, Ellingsgaard H, Halban PA, and Ehses JA. Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends Endocrinol Metab 21: 261-267, 2010.
55. Donath MY, Størling J, Maedler K, and Mandrup-Poulsen T. Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 81: 455-470, 2003.
56. Ehses JA, Perren A, Eppler E, Ribaux P, Pospisilik JA, Maor-Cahn R, Gueripel X, Ellingsgaard H, Schneider MK, Biollaz G, Fontana A, Reinecke M, Homo-Delarche F, and Donath MY. Increased number of islet-associated macro-phages in type 2 diabetes. Diabetes 56: 2356-2370, 2007.
57. Farvid MS, Siassi F, Jalali M, Hosseini M, and Saadat N. The impact of vitamin and=or mineral supplementation on lipid profiles in type 2 diabetes. Diabetes Res Clin Pract 65: 21-28, 2004. (Pubitemid 38649045)
58. Faure P, Benhamou PY, Perard A, Halimi S, and Roussel AM. Lipid peroxidation in insulin-dependent diabetic patients with early retina degenerative lesions: effects of an oral zinc supplementation. Eur J Clin Nutr 49: 282-288, 1995.
59. Faure P, Lafond JL, Coudray C, Rossini E, Halimi S, Favier A, and Blache D. Zinc prevents the structural and functional properties of free radical treated-insulin. Biochim Biophys Acta 1209: 260-264, 1994.
60. Feillet-Coudray C, Meunier N, Bayle D, Brandolini-Bunlon M, Andriollo-Sanchez M, O'Connor JM, Maiani G, Roussel AM, Mazur A, and Coudray C. Effect of zinc supplementation on in vitro copper-induced oxidation of low-density lipoproteins in healthy French subjects aged 55-70 years: the Zenith Study. Br J Nutr 95: 1134-1142, 2006.
61. Fischer PWF, Giroux A, and L'abbé MR. Effect of zinc supplementation on copper status in adult man. Am J Clin Nutr: 40, 743-746. 1984.
62. Fliss H and Ménard M. Hypochlorous acid-induced mobilization of zinc from metalloproteins. Arch Biochem Biophys 287: 175-179, 1991.
63. Fliss H and Ménard M. Oxidant-induced mobilization of zinc from metallothionein. Arch Biochem Biophys 293: 195-199, 1992.
64. Forbes IJ, Zalewski PD, Giannakis C, Petkoff HS, and Cowled PA. Interaction between protein kinase C and regulatory ligand is enhanced by a chelatable pool of cellular zinc. Biochim Biophys Acta 1053: 113-117, 1990.
65. Fortuño A, Oliván S, Beloqui O, San José G, Moreno MU, Díez J, and Zalba G. Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension. J Hypertens 22: 2169-2175, 2004.
66. Foster M, Hancock D, and Samman S. Co-ordinated regulation of zinc transporter mRNA expression in healthy males and females. Proc Nutr Soc Aust 33: 99, 2009.
67. Foster M, Petocz P, and Samman S. Effects of zinc on plasma lipoprotein cholesterol concentrations in humans: a meta-analysis of randomised controlled trials. Atherosclerosis 210: 344-352, 2010.
68. Freeland-Graves JH, Friedman BJ, Han WH, Shorey RL, and Young R. Effect of zinc supplementation on plasma high-density lipoprotein cholesterol and zinc. Am J Clin Nutr 35: 988-992, 1982.
69. Frithz G and Ronquist G. Increased red cell content of zinc in essential hypertension. Acta Med Scand 205: 647-649, 1979.
70. Galan P, Preziosi P, Monget AL, Richard MJ, Arnaud J, Lesourd B, Girodon F, Alferez MJ, Bourgeois C, Keller H, Favier A, and Hercberg S. Effects of trace element and=or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Int J Vitam Nutr Res 67: 450-460, 1997.
71. Gatto LM and Samman S. The effect of zinc supplementation on plasma lipids and low-density lipoprotein oxidation in males. Free Radic Biol Med 19: 517-521, 1995.
72. Giacconi R, Bonfigli AR, Testa R, Sirolla C, Cipriano C, Marra M, Muti E, Malavolta M, Costarelli L, Piacenza F, Tesei S, and Mocchegiani E. \+647 A=C and \+1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications. Mol Genet Metabol 94: 98-104, 2008.
73. Giacconi R, Muti E, Malavolta M, Cipriano C, Costarelli L, Bernardini G, Gasparini N, Mariani E, Saba V, Boccoli G, and Mocchegiani E. The \+838 C=G MT2A polymorphism, metals, and the inflammatory=immune response in carotid artery stenosis in elderly people. Mol Med 13: 388-395, 2007.
74. Girodon F, Blache D, Monget AL, Lombart M, Brunet-Lecompte P, Arnaud J, Richard MJ, and Galan P. Effect of a two-year supplementation with low doses of antioxidant vitamins and=or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters. J Am Coll Nutr 16: 357-365, 1997.
75. Gordon PR, Woodruff CW, Anderson HL, and O'Dell BL. Effect of acute zinc deprivation on plasma zinc and platelet aggregation in adult males. Am J Clin Nutr 35: 113-119, 1982.
76. Gorelik O, Almoznino-Sarafian D, Feder I, Wachsman O, Alon I, Litvinjuk V, Roshovsky M, Modai D, and Cohen N. Dietary intake of various nutrients in older patients with congestive heart failure. Cardiology 99: 177-181, 2003.
77. Gupta R, Garg VK, Mathur DK, and Goyal RK. Oral zinc therapy in diabetic neuropathy. J Assoc Physicians India 46: 939-942, 1998.
78. 2\+ in pancreatic a-cells. J Biol Chem 283: 10184-10197, 2008.
79. Ha KN, Chen Y, Cai J, and Sternberg P. Increased gluta-thione synthesis through an ARE-Nrf2-dependent pathway by zinc in the RPE: implication for protection against oxi-dative stress. Invest Ophthalmol Vis Sci 47: 2709-2715, 2006.
80. Haase H and Maret W. Fluctuations of cellular, available zinc modulate insulin signaling via inhibition of protein tyrosine phosphatases. J Trace Elem Med Biol 19: 37-42, 2005.
81. Haase H and Maret W. Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. Biometals 18: 333-338, 2005.
82. Haase H, Ober-Blöbaum JL, Engelhardt G, Hebel S, Heit A, Heine H, and Rink L. Zinc signals are essential for lipo-polysaccharide-induced signal transduction in monocytes. J Immunol 181: 6491-6502, 2008.
83. Harlan WR, Landis JR, Schmouder RL, Goldstein NG, and Harlan LC. Blood lead and blood pressure. Relationship in the adolescent and adult US population. JAMA 253: 530-534, 1985.
84. Heinz U, Kiefer M, Tholey A, and Adolph HW. On the competition for available zinc. J Biol Chem 280: 3197-3207, 2005.
85. Hennig B, Meerarani P, Toborek M, and McClain CJ. An-tioxidant-like properties of zinc in activated endothelial cells. J Am Coll Nutr 18: 152-158, 1999.
86. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, and Briancon S. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164: 2335-2342, 2004.
87. 2\+ and regulates ion transport. Proc Natl Acad Sci USA 98: 11749-11754, 2001.
88. Hershfinkel M, Silverman WF, and Sekler I. The zinc sensing receptor, a link between zinc and cell signaling. Mol Med 13: 331-336, 2007.
89. Hininger-Favier I, Andriollo-Sanchez M, Arnaud J, Meu-nier N, Bord S, Graham C, Polito A, Maiani G, O'Connor JM, Coudray C, and Roussel AM. Age-and sex-dependent effects of long-term zinc supplementation on essential trace element status and lipid metabolism in European subjects: the Zenith Study. Br J Nutr 97: 569-578, 2007.
90. Hooper PL, Visconti L, Garry PJ, and Johnson GE. Zinc lowers high-density lipoprotein-cholesterol levels. JAMA 244: 1960-1961, 1980.
91. Hubbard SR, Bishop WR, Kirschmeier P, George SJ, Cramer SP, and Hendrickson WA. Identification and characterization of zinc binding sites in protein kinase C. Science 254: 1776-1779, 1991.
92. Hughes S and Samman S. The effect of zinc supplementation in humans on plasma lipids, antioxidant status and thrombogenesis. J Am Coll Nutr 25: 285-291, 2006.
93. Hunaiti AA and Saleh MS. Effects of iron, zinc, calcium, and vitamins on the activity and contents of human pla-cental copper=zinc and manganese superoxide dismutases. Biol Trace Elem Res 54: 231-238, 1996.
94. Ibs KH and Rink L. Zinc-altered immune function. J Nutr 133: 1452S-1456S, 2003.
95. Ilbert M, Graf PCF, and Jakob U. Zinc center as redox switch\-new function for an old motif. Antioxid Redox Signal 8: 835-846, 2006.
96. Inoue M, Kishimoto A, Takai Y, and Nishizuka Y. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. II. Proenzyme and its activation by calcium-dependent protease from rat brain. J Biol Chem 252: 7610-7616, 1977. (Pubitemid 8227337)
97. Jakob U, Muse W, Eser M, and Bardwell JCA. Chaperone activity with a redox switch. Cell 96: 341-352, 1999.
98. Jansen J, Karges W, and Rink L. Zinc and diabetes\-clinical links and molecular mechanisms. J Nutr Biochem 20: 399-417, 2009.
99. Jirakulaporn T and Muslin AJ. Cation diffusion facilitator proteins modulate Raf-1 activity. J Biol Chem 279: 27807-27815, 2004.
100. Kadhim HM, Ismail SH, Hussein KI, Bakir IH, Sahib AS, Khalaf BH, and Hussain SA. Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly controlled with metformin. J Pineal Res 41: 189-193, 2006.
101. Karagulova G, Yue Y, Moreyra A, Boutjdir M, and Kor-ichneva I. Protective role of intracellular zinc in myocardial ischemic=reperfusion is associated with preservation of protein kinase C isoforms. J Pharmacol Exp Ther 321: 517-525, 2007.
102. Kellerer M, Koch M, Metzinger E, Mushack J, Capp E, and Haring HU. Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia 40: 1358-1362, 1997.
103. Kim BJ, Kim YH, Kim S, Kim JW, Koh JY, Oh SH, Lee MK, Kim KW, and Lee MS. Zinc as a paracrine effector in pancreatic islet cell death. Diabetes 49: 367-372, 2000.
104. 2\+-induced NF-kB-dependent tran-scriptional activity involves site-specific p65=RelA phos-phorylation. Cell Signal 19: 538-546, 2007.
105. 2\+-induced IL-8 expression involves AP-1, JNK, and ERK activities in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 290: L1028-L1035, 2006.
106. King GL and Loeken MR. Hyperglycemia-induced oxida-tive stress in diabetic complications. Histochem Cell Biol 122: 333-338, 2004.
107. King JC and Cousins RJ. Zinc. In: Modern Nutrition in Health and Disease. Shils ME, Shike M, Ross AC, Caballero B, and Cousins RJ. Baltimore, MD: Lippincott Williams and Wilkins, 271-285, 2006.
108. King JC, Shames DM, and Woodhouse LR. Zinc homeo-stasis in humans. J Nutr 130: 1360S-1366S, 2000.
109. Kirchhoff K, Machicao F, Haupt A, Schäfer SA, Tschritter O, Staiger H, Stefan N, Häring HU, and Fritsche A. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Dia-betologia 51: 597-601, 2008.
110. Klevay LM, Canfield WK, Gallagher SK, Henriksen LK, Lukaski HC, Bolonchuk W, Johnson LK, Milne DB, and Sandstead HH. Decreased glucose tolerance in two men during experimental copper depletion. Nutr Rep Int 33: 371-382, 1986.
111. Klevay LM, Inman L, Johnson LK, Lawler M, Mahalko JR, Milne DB, Lukaski HC, Bolonchuk W, and Sandstead HH. Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism 33: 1112-1118, 1984.
112. Knapp LT and Klann E. Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content. J Biol Chem 275: 24136-24145, 2000.
113. Konukoglu D, Turhan MS, Ercan M, and Serin O. Relationship between plasma leptin and zinc levels and the effect of insulin and oxidative stress on leptin levels in obese diabetic patients. J Nutr Biochem 15: 757-760, 2004.
114. Krezel A and Maret W. Zinc-buffering capacity of a eu-karyotic cell at physiological pZn. J Biol Inorg Chem 11: 1049-1062, 2006.
115. Kröncke K-D, Fehsel K, Schmidt T, Zenke FT, Dasting I, Wesener JR, Bettermann H, Breunig KD, and Kolb-Bacho-fen V. Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9. Biochem Biophys Res Commun 200: 1105-1110, 1994.
116. Kröncke KD and Klotz LO. Zinc fingers as biologic redox switches? Antioxid Redox Signal 11: 1015-1027, 2009.
117. Kruse-Jarres JD. The significance of zinc for humoral and cellular immunity. J Trace Elem Electrolytes Health Dis 3: 1-8, 1989.
118. L'abbé MR and Fischer PWF. The effects of high dietary zinc and copper deficiency on the activity of copper-requiring metalloenzymes in the growing rat. J Nutr: 114, 813-822, 1984.
119. Lee DH, Folsom AR, and Jacobs DR. Iron, zinc, and alcohol consumption and mortality from cardiovascular diseases: the Iowa Women's Health Study. Am J Clin Nutr 81: 787-791, 2005.
120. Lee S, Chanoit G, McIntosh R, Zvara DA, and Xu Z. Molecular mechanism underlying Akt activation in zinc-induced cardioprotection. Am J Physiol Heart Circ Physiol 297: H569-H575, 2009.
121. Lengyel I, Fieuw-Makaroff S, Hall AL, Sim AT, Rostas JA, and Dunkley PR. Modulation of the phosphorylation and activity of calcium=calmodulin-dependent protein kinase II by zinc. J Neurochem 75: 594-605, 2000.
122. Lichten LA and Cousins RJ. Mammalian zinc transporters: nutritional and physiological regulation. Annu Rev Nutr 29: 153-176, 2009.
123. Lu SC. Regulation of glutathione synthesis. Mol Aspects Med 30: 42-59, 2009.
124. Mackenzie GG, Paola Zago M, Keen CL, and Oteiza PI. Low intracellular zinc impairs the translocation of activated NF-kB to the nuclei in human neuroblastoma IMR-32 cells. J Biol Chem 277: 34610-34617, 2002.
125. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, and Donath MY. Glucose-induced beta cell production of IL1-beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110: 851-860, 2002.
126. Malavolta M, Piacenza F, Costarelli L, Giacconi R, Muti E, Cipriano C, Tesei S, Spezia S, and Mocchegiani E. Combining UHR-SEC-HPLC-ICP-MS with flow cytometry to quantify metallothioneins and to study zinc homeostasis in human PBMC. J Anal At Spectrom 22: 1193-1198, 2007.
127. Mangian HF, Lee RG, Paul GL, Emmert JL, and Shay NF. Zinc deficiency suppresses plasma leptin concentrations in rats. J Nutr Biochem 9: 47-51, 1998.
128. Mantzoros CS, Prasad AS, Beck FWJ, Grabowski S, Kaplan J, Adair C, and Brewer GJ. Zinc may regulate serum leptin concentrations in humans. J Am Coll Nutr 17: 270-275, 1998.
129. Maret W. Crosstalk of the group IIa and IIb metals calcium and zinc in cellular signaling. Proc Natl Acad Sci USA 98: 12325-12327, 2001.
130. Maret W. Molecular aspects of human cellular zinc ho-meostasis: redox control of zinc potentials and zinc signals. Biometals 22: 149-157, 2009.
131. Maret W. Oxidative metal release from metallothionein via zinc-thiol=disulfide interchange. Proc Natl Acad Sci USA 91: 237-241, 1994.
132. Maret W. Zinc and sulfur: a critical biological partnership. Biochemistry 43: 3301-3309, 2004.
133. Maret W. Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxid Redox Signal 8: 1419-1441, 2006.
134. Mariani E, Mangialasche F, Feliziani FT, Cecchetti R, Ma-lavolta M, Bastiani P, Baglioni M, Dedoussis G, Fulop T, Herbein G, Jajte J, Monti D, Rink L, Mocchegiani E, and Mecocci P. Effects of zinc supplementation on antioxidant enzyme activities in healthy old subjects. Exp Gerontol 43: 445-451, 2008.
135. Mark SD, Wang W, Fraumeni JF, Li JY, Taylor PR, Wang GQ, Dawsey SM, Li B, and Blot WJ. Do nutritional supplements lower the risk of stroke or hypertension? Epidemiology 9: 9-15, 1998.
136. Marx G, Krugliak J, and Shaklai M. Nutritional zinc increases platelet reactivity. Am J Hematol 38: 161-165, 1991.
137. Matsunaga Y, Kawai Y, Kohda Y, and Gemba M. Involvement of activation of NADPH oxidase and extracellular signal-regulated kinase (ERK) in renal cell injury induced by zinc. J Toxicol Sci 30: 135-44, 2005.
138. 2\+ mobilisation in hepatocytes. Biochem J 339: 555-561, 1999.
139. Meerarani P, Ramadass P, Toborek M, Bauer HC, Bauer H, and Hennig B. Zinc protects against apoptosis of endo-thelial cells induced by linoleic acid and tumor necrosis factor alpha. Am J Clin Nutr 71: 81-87, 2000.
140. 2 and antioxi-dants have opposite effects on activation of NF-kB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12: 2005-2015, 1993.
141. Milne DB, Canfield WK, Mahalko JR, and Sandstead HH. Effect of dietary zinc on whole body surface loss of zinc: impact on estimation of zinc retention by balance method. Am J Clin Nutr 38: 181-186, 1983.
142. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsili-mingas N, Walter U, Forstermann U, Meinertz T, Griend-ling K, and Munzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide=cGMP signaling. Circ Res 90: E58-E65, 2002.
143. Morrison CD, Huypens P, Stewart LK, and Gettys TW. Implications of crosstalk between leptin and insulin signaling during the development of diet-induced obesity. Biochim Biophys Acta 1792: 409-416, 2009.
144. Niewoehner CB, Allen JI, Boosalis M, Levine AS, and Morley JE. Role of zinc supplementation in type II diabetes mellitus. Am J Med 81: 63-68, 1986.
145. Oh SH, Deagan JT, Whanger PD, and Weswig PH. Biological function of metallothionein. V. Its induction in rats by various stresses. Am J Physiol 234: E282-E285, 1978.
146. Olin KL, Golub MS, Gershwin ME, Hendrickx AG, Lon-nerdal B, and Keen CL. Extracellular superoxide dismutase activity is affected by dietary zinc intake in nonhuman primate and rodent models. Am J Clin Nutr 61: 1263-1267, 1995.
147. Onosaka S and Cherian MG. The induced synthesis of metallothionein in various tissues of rats in response to metals. II. Influence of zinc status and specific effect on pancreatic metallothionein. Toxicology 23: 11-20, 1982.
148. Oteiza PI, Clegg MS, Zago MP, and Keen CL. Zinc deficiency induces oxidative stress and AP-1 activation in 3T3 cells. Free Radic Biol Med 28: 1091-1099, 2000.
149. Overbeck S, Uciechowski P, Ackland ML, Ford D, and Rink L. Intracellular zinc homeostasis in leukocyte subsets is regulated by different expression of zinc exporters ZnT-1 to ZnT-9. J Leukoc Biol 83: 369-380, 2008.
150. Paik HY, Joung H, Lee JY, Lee HK, King JC, and Keen CL. Serum extracellular superoxide dismutase activity as an indicator of zinc status in humans. Biol Trace Elem Res 69: 45-57, 1999.
151. Palmiter RD and Findley SD. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J 14: 639-649, 1995.
152. Panemangalore M and Bebe FN. Effect of high dietary zinc on plasma ceruloplasmin and erythrocyte superoxide dis-mutase activities in copper-depleted and repleted rats. Biol Trace Elem Res 55: 111-126, 1996.
153. Parham M, Amini M, Aminorroaya A, and Heidarian E. Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: a double blind, randomized, placebo-controlled, cross-over trial. Rev Diabet Stud 5: 102-109, 2008.
154. Park JA and Koh JY. Induction of an immediate early gene egr-1 by zinc through extracellular signal-regulated kinase activation in cortical culture: its role in zinc-induced neu-ronal death. J Neurochem 73: 450-456, 1999.
155. Partida-Hernandez G, Arreola F, Fenton B, Cabeza M, Román-Ramos R, and Revilla-Monsalve MC. Effect of zinc replacement on lipids and lipoproteins in type 2-diabetic patients. Biomed Pharmacother 60: 161-168, 2006.
156. Pasterkamp G, van Keulen JK, and de Kleijn DPV. Role of toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur J Clin Invest 34: 328-334, 2004.
157. Pearce LL, Gandley RE, Han W, Wasserloos K, Stitt M, Kanai AJ, McLaughlin MK, Pitt BR, and Levitan ES. Role of metallothionein in nitric oxide signaling revealed by a green fluorescent fusion protein. Proc Natl Acad Sci USA 97: 477-482, 2000.
158. Persoon-Rothert M, van der Valk-Kokshoorn EJ, Egas-Kenniphaas JM, Mauve I, and van der Laarse A. Iso-proterenol-induced cytotoxicity in neonatal rat heart cell cultures is mediated by free radical formation. J Mol Cell Cardiol 21: 1285-1291, 1989.
159. Pilon M, Wu R, Huot-Marchand JE, deBlois D, de Cham-plain J, and Couture R. Effect of chronic inhibition of nitric oxide on hypertension, insulin resistance, and cardiovascular remodelling in glucose-fed rats. J Cardiovasc Pharmacol 53: 405-413, 2009.
160. Pilz S, Dobnig H, Winklhofer-Roob BM, Renner W, Seel-horst U, Wellnitz B, Boehm BO, and März W. Low serum zinc concentrations predict mortality in patients referred to coronary angiography. Br J Nutr 101: 1534-1540, 2009.
161. Powell SR. The antioxidant properties of zinc. J Nutr 130: 1447S-1454S, 2000.
162. Powell SR, Hall D, Aiuto L, Wapnir RA, Teichberg S, and Tortolani AJ. Zinc improves postischemic recovery of isolated rat hearts through inhibition of oxidative stress. Am J Physiol 266: H2497-H2507, 1994.
163. Powell SR, Nelson RL, Finnerty J, Alexander D, Pottanat G, Kooker K, Schiff RJ, Moyse J, Teichberg S, and Tortolani AJ. Zinc-bis-histidinate
164. Prasad AS. Zinc and immunity. Mol Cell Biochem 188: 63-69, 1998.
165. Prasad AS. Zinc in human health: effect of zinc on immune cells. Mol Med 14: 353-357, 2008.
166. Prasad AS, Bao B, Beck FWJ, and Sarkar FH. Correction of interleukin-2 gene expression by in vitro zinc addition to mononuclear cells from zinc deficient human subjects: a specific test for zinc deficiency in humans. Transl Res 148: 325-333, 2006.
167. Prasad AS, Beck FWJ, Bao B, Fitzgerald JT, Snell DC, Steinberg JD, and Cardozo LJ. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 85: 837-844, 2007.
168. Preziosi P, Galan P, Herbeth B, Valeix P, Roussel AM, Malvy D, Paul-Dauphin A, Arnaud J, Richard MJ, Briancon S, Favier A, and Hercberg S. Effects of supplementation with a combination of antioxidant vitamins and trace elements, at nutritional doses, on biochemical indicators and markers of the antioxidant system in adult subjects. J Am Coll Nutr 17: 244-249, 1988.
169. Reunanen A, Knekt P, Marniemi J, Maki J, Maatela J, and Aromaa A. Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur J Clin Nutr 50: 431-437, 1996.
170. Rink L and Gabriel P. Zinc and the immune system. Proc Nutr Soc 59: 541-552, 2000.
171. Ripa S, Ripa R, and Giustiniani S. Are failured cardiomy-opathies a zinc-deficit related disease A study on Zn and Cu in patients with chronic failured dilated and hypertrophic cardiomyopathies. Minerva Med 89: 397-403, 1998.
172. Rogalska J, Brzóska MM, Roszczenko A, and Moniuszko-Jakoniuk J. Enhanced zinc consumption prevents cadmium-induced alterations in lipid metabolism in male rats. Chem Biol Interact 177: 142-152, 2009.
173. Roussel AM, Kerkeni A, Zouari N, Mahjoub S, Matheau JM, and Anderson RA. Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr 22:316-321, 2003.
174. Rowe DJ and Bobilya DJ. Albumin facilitates zinc acquisition by endothelial cells. Proc Soc Exp Biol Med 224: 178-186, 2000.
175. Ruz M, Cavan KR, Bettger WJ, Fischer PWF, and Gibson RS. Indices of iron and copper status during experimentally induced, marginal zinc deficiency in humans. Biol Trace Elem Res 34: 197-212, 1992.
176. Samman S. Dietary versus cellular zinc: the antioxidant paradox. Free Radic Biol Med 14: 95-96, 1993.
177. Samman S and Roberts DCK. The effect of zinc supplements on lipoproteins and copper status. Atherosclerosis 70: 247-252, 1988.
178. Samman S and Roberts DCK. The effect of zinc supplements on plasma zinc and copper levels and the reported symptoms of healthy volunteers. Med J Aust 146: 246-249, 1987.
179. Sato M, Mehra RK, and Bremner I. Measurement of plasma metallothionein-I in the assessment of the zinc status of zinc-deficient and stressed rats. J Nutr 114: 1683-1689, 1984.
180. Sato M, Yanagisawa H, Nojim Y, Tamura J, and Wada O. Zn deficiency aggravates hypertension in spontaneously hypertensive rats: possible role of Cu=Zn-superoxide dis-mutase. Clin Exp Hypertens 24: 355-370, 2002.
181. Schott-Ohly P, Lgssiar A, Partke HJ, Hassan M, Friesen N, and Gleichmann H. Prevention of spontaneous and experimentally induced diabetes in mice with zinc sulfate-enriched drinking water is associated with activation and reduction of NF-kB and AP-1 in islets, respectively. Exp Biol Med 229: 1177-1185, 2004.
182. Scott DA. Crystalline insulin. Biochem J 28: 1592-1602, 1934.
183. Singal PK, Dhillon KS, Beamish RE, and Dhallas NS. Protective effect of zinc against catecholamine-induced myo-cardial changes electrocardiographic and ultrastructural studies. Lab Invest 44: 426-433, 1981.
184. Singh RB, Niaz MA, Rastogi SS, Bajaj S, Gaoli Z, and Shoumin Z. Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr 17: 564-570, 1998.
185. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Poly-chronakos C, and Froguel P. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445: 881-885, 2007.
186. Soinio M, Marniemi J, Laakso M, Pyörälä K, Lehto S, and Rönnemaa T. Serum zinc level and coronary heart disease events in patients with type 2 diabetes. Diabetes Care 30: 523-528, 2007.
187. 2\+ release. Proc Natl Acad Sci USA 100: 13952-13957, 2003.
188. Sparks JD and Dong HH. FoxO1 and hepatic lipid metabolism. Curr Opin Lipidol 20: 217-226, 2009.
189. Spranger J, Kroke A, Möhlig M, Hoffman K, Bergmann MM, Ristow M, Boeing H, and Pfeiffer AF. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52: 812-817, 2003.
190. St. Croix CM, Wasserloos KJ, Dineley KE, Reynolds IJ, Levitan ES, and Pitt BR. Nitric oxide induced changes in intracellular zinc homeostasis are mediated by me-tallothionein=thionein. Am J Physiol Lung Cell Mol Physiol 282: L185-L192, 2002.
191. Steinberg D. Antioxidants and atherosclerosis: A current assessment. Circulation 84: 1420-1425, 1991.
192. Steinhardt HJ and Adibi SA. Interaction between transport of zinc and other solutes in human intestine. Am J Physiol Gastrointest Liver Physiol 247: G176-G182, 1984.
193. Stocker R and Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 84: 1381-1478, 2004.
194. Sun Q, van Dam RM, Willet WC, and Hu FB. Prospective study of zinc intake and risk of type 2 diabetes in women. Diabetes Care 32: 629-634, 2009.
195. Swanson CA, Mansourian R, Dirren H, and Rapin CH. Zinc status of healthy elderly adults: response to supplementation. Am J Clin Nutr 48: 343-349, 1988.
196. Szczurek EI, Bjornsson CS, and Taylor CG. Dietary zinc deficiency and repletion modulate metallothionein im-munolocalization and concentration in small intestine and liver of rats. J Nutr 131: 2132-2138, 2001.
197. Tamura T, Olin KL, Goldenburg RL, Johnston KE, Dubard MB, and Keen CL. Plasma extracellular superoxide dis-mutase activity in healthy pregnant women is not influenced by zinc supplementation. Biol Trace Elem Res 80: 107-113, 2001.
198. Tate DJ Jr., Miceli MV, and Newsome DA. Zinc protects against oxidative damage in cultured human retinal pigment epithelial cells. Free Radic Biol Med 26: 704-713, 1999.
199. Taysi S, Cikman O, Kaya A, Demircan B, Gumustekin K, Yilmaz A, Boyuk A, Keles M, Akyuz M, and Turkeli M. Increased oxidant stress and decreased antioxidant status in erythrocytes of rats fed with zinc deficient diet. Biol Trace Elem Res 123: 161-167, 2008.
200. Thomas EA, Bailey LB, Kauwell GA, Lee DY, and Cousins RJ. Erythrocyte metallothionein response to dietary zinc in humans. J Nutr 122: 2408-2414, 1992.
201. Thomas JP, Bachowski GL, and Girotti AW. Inhibition of cell membrane lipid peroxidation by cadmium-and zinc-metallothionein. Biochim Biophys Acta 884: 448-461, 1986.
202. Thomas SR, Witting PK, and Drummond GR. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 10: 1713-1765, 2008.
203. Thornally PJ and Vasak M. Possible role for metallothio-nein in protection against radiation-induced oxidative stress: kinetics and mechanism of its reaction with super-oxide and hydroxyl radicals. Biochim Biophys Acta 827: 36-44, 1985.
204. Toledano MB and Leonard WJ. Modulation of transcription factor NF-kB binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA 88: 4328-4332, 1991.
205. Truong-Tran AQ, Ho LH, Chai F, and Zalewski PD. Cellular zinc fluxes and the regulation of apoptosis=gene-directed cell death. J Nutr 130: 1459S-1466S, 2000.
206. Tubek S. Role of zinc in regulation of arterial blood pressure and in the etiopathogenesis of arterial hypertension. Biol Trace Elem Res 117: 39-51, 2007.
207. Valentine RA, Jackson KA, Christie GR, Mathers JC, Taylor PM, and Ford D. ZnT5 variant B is a bidirectional zinc transporter and mediates zinc uptake in human intestinal caco-2 cells. J Biol Chem 282: 14389-14393, 2007.
208. Vallee BL. Biochemistry, physiology and pathology of zinc. Physiol Rev 39: 443-490, 1959.
209. Vallee BL and Auld DS. Zinc coordination, function, and structure of zinc enzymes and other proteins. Biochemistry 29: 5647-5659, 1990.
210. Vallee BL and Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev 73: 79-118, 1993.
211. Vecchione C, Maffei A, Colella S, Aretini A, Poulet R, Frati G, Gentile MT, Fratta L, Trimarco V, Trimarco B, and Lembo G. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 51: 168-173, 2002.
212. Vivoli G, Bergomi M, Rovesti S, Pinotti M, and Case-lgrandi E. Zinc, copper, and zinc-or copper-dependent enzymes in human hypertension. Biol Trace Elem Res 49: 97-106, 1995.
213. Von Bülow V, Dubben S, Engelhardt G, Hebel S, Plümäkers B, Heine H, Rink L, and Haase H. Zinc-dependent suppression of TNF-a production is mediated by protein kinase A-induced inhibition of Raf-1, IkB Kinase b, and NF-kB. J Immunol 179: 4180-4186, 2007.
214. Wang C, Li Y, Zhu K, Dong YM, and Sun CH. Effects of supplementation with multivitamin and mineral on blood pressure and C-reactive protein in obese Chinese women with increased cardiovascular disease risk. Asia Pac J Clin Nutr 18: 121-130, 2009.
215. Wang J, Song Y, Elsherif L, Song Z, Zhou G, Prabhu SD, Saari JT, and Cai L. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardio-myopathy by zinc supplementation. Circulation 113: 544-554, 2006.
216. Wang K, Zhou B, Kuo YM, Zemansky J, and Gitschier J. A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am J Hum Genet 71: 66-73, 2002.
217. Webster KA, Prentice H, and Bishopric NH. Oxidation of zinc finger transcription factors: physiological consequences. Antioxid Redox Signal 3: 535-548, 2001.
218. Wellinghausen N, Kirchner H, and Rink L. The im-munobiology of zinc. Immunol Today 18: 519-521, 1997.
219. Wilcox DE, Schenk AD, Feldman BM, and Xu Y. Oxidation of zinc-binding cysteine residues in transcription factor proteins. Antioxid Redox Signal 3: 549-563, 2001.
220. Wilkins GM and Leake DS. The oxidation of low density lipoprotein by cells or iron is inhibited by zinc. FEBS Lett 341: 259-262, 1994.
221. Willcox JK, Ash SL, and Catignani GL. Antioxidants and prevention of chronic diseases. Crit Rev Food Sci Nutr 44: 275-295, 2004.
222. Williams RJP. The biochemistry of zinc. Polyhedron 6: 61-69, 1987.
223. Wiseman DA, Wells SM, Hubbard M, Welker JE, and Black SM. Alterations in zinc homeostasis underlie endothelial cell death induced by oxidative stress from acute exposure to hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol 292: L165-L177, 2007.
224. Witte KK, Nikitin NP, Parker AC, von Haehling S, Volk HD, Anker SD, Clark AL, and Cleland JG. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 26: 2238-2244, 2005.
225. Wu W, Wang X, Zhang W, Reed W, Samet JM, Whang YE, and Ghio AJ. Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells. J Biol Chem 278: 28258-28263, 2003.
226. Wuehler SE, Peerson JM, and Brown KH. Use of national food balance data to estimate the adequacy of zinc in national food supplies: methodology and regional estimates. Public Health Nutr 8: 812-819, 2005.
227. Xu J, Xie Z, Reece R, Pimental D, and Zou MH. Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid. Role of NAD(P)H oxidase-derived superoxide and peroxynitrite. Arterioscler Thromb Vasc Biol 26: 2688-2695, 2006.
228. Yadrick MK, Kenney MA, and Winterfeldt EA. Iron, copper, and zinc status: response to supplementation with zinc or zinc and iron in adult females. Am J Clin Nutr 49: 145-150, 1989.
229. Yamasaki S, Sakata-Sogawa K, Hasegawa A, Suzuki T, Kabu K, Sato E, Kurosaki T, Yamashita S, Tokunaga M, Nishida K, and Hirano T. Zinc is a novel intracellular second messenger. J Cell Biol 177: 637-645, 2007.
230. Ye B, Maret W, and Vallee BL. Zinc metallothionein imported into liver mitochondria modulates respiration. Proc Natl Acad Sci USA 98: 2317-2322, 2001.
231. 2. Antioxid Redox Signal 7: 1773-1782, 2005.
232. Zavaroni I, Dall'Aglio E, Bruschi OAF, Bonora E, Pezzar-ossa A, and Butturini U. Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 55: 259-266, 1985.
233. Zhang W, Patil S, Chauhan B, Guo S, Powell DR, Le J, Klotsas A, Matika R, Xiao X, Franks R, Heidenreich KA, Sajan MP, Farese RV, Stolz DB, Tso P, Koo S-H, Mon-tminy M, and Unterman TG. FoxO1 regulates multiple metabolic pathways in the liver. J Biol Chem 281: 10105-10117, 2006.
234. Zhou L, Xiang W, Potts J, Floyd M, Sharan C, Yang H, Ross J, Nyanda AM, and Guo Z. Reduction in extracellular superoxide dismutase activity in African-American patients with hypertension. Free Radic Biol Med 41: 1384-1391, 2006.
235. Zou MH, Shi C, and Cohen RA. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109: 817-826, 2002.
236. Zureik M, Galan P, Bertrais S, Mennen L, Czernichow S, Blacher J, Ducimetière P, and Hercberg S. Effects of long-term daily low-dose supplementation with antioxi-dant vitamins and minerals on structure and function of large arteries. Arterioscler Thromb Vasc Biol 24: 1485-1491, 2004.